Brought to you by 
Zeneca acquires Astra for $31bn
Jan 1999
Executive Summary
In an all-stock transaction, Zeneca and Astra will merge, creating a new company, AstraZeneca, with a combined market cap of $67bn. Astra stockholders will hold 46.5% and Zeneca's 53.5% of the new entity, valuing the purchase at $31bn.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Zeneca acquires Astra for $31bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice